A New Name in Weight Loss Drugs

Novo Nordisk and Eli Lilly have soared on the popularity of GLP-1 weight loss drugs. Now Hims & Hers is trying to get in on the action with a more available and affordable option.

Dow Jones 40,000: Investors Dig In

We also talk with Whole Foods co-founder John Mackey about his new book, “The Whole Story: Adventures in Love, Life, and Capitalism.”